Ciprofloxacin as a Potential Radio-Sensitizer to Tumor Cells and a Radio-Protectant for Normal Cells: Differential Effects on Γ-H2ax Formation, P53 Phosphorylation, BCL-2 Production, and Cell Death

Molecular and Cellular Biochemistry - United States
doi 10.1007/s11010-014-2053-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Histone Deacetylase Inhibitors Valproic Acid and Depsipeptide Sensitize Retinoblastoma Cells to Radiotherapy by Increasing H2AX Phosphorylation and P53 Acetylation-Phosphorylation

International Journal of Oncology
Cancer ResearchOncology
2010English

Disulfiram (Antabuse®) Acts as Potent Radio-Chemo Sensitizer of HNSCC and Derived Stem Cells In-Vitro

2018English

Effects of Zerumbone on Proliferation and Apoptosis of Esophageal Cancer Cells and on P53 and BCL-2 Expression Levels

Oncology Letters
Cancer ResearchOncology
2018English

Assessment of Γ-H2ax Levels in Circulating Tumor Cells From Patients Receiving Chemotherapy

Frontiers in Oncology
Cancer ResearchOncology
2012English

BCL-2 Orchestrates a Cross-Talk Between Endothelial and Tumor Cells That Promotes Tumor Growth

Cancer Research
Cancer ResearchOncology
2007English

Genistein Decreases Cellular Redox Potential, Partially Suppresses Cell Growth in HL-60 Leukemia Cells and Sensitizes Cells to Γ-Radiation-Induced Cell Death

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Radio-Selective Effects of a Natural Occurring Muscle-Derived Dipeptide in A549 and Normal Cell Lines

Scientific Reports
Multidisciplinary
2019English

DNA Methylation as a Potential Diagnosis Indicator for Rapid Discrimination of Rare Cancer Cells and Normal Cells

Scientific Reports
Multidisciplinary
2015English

A Joint Model for Radio and Γ-Ray Emission From Pulsars

Symposium - International Astronomical Union
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy